[{"address1": "4 Kingsbury Avenue", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "617 607 0800", "fax": "617 607 0530", "website": "https://www.enanta.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay R. Luly Ph.D.", "age": 68, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 1231428, "exercisedValue": 0, "unexercisedValue": 67815}, {"maxAge": 1, "name": "Dr. Yat Sun Or Ph.D.", "age": 72, "title": "Chief Scientific Officer", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 740108, "exercisedValue": 0, "unexercisedValue": 22091}, {"maxAge": 1, "name": "Mr. Matthew P. Kowalsky J.D.", "age": 51, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 575652, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott T. Rottinghaus M.D.", "age": 50, "title": "Chief Medical Office", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 776138, "exercisedValue": 43483, "unexercisedValue": 14728}, {"maxAge": 1, "name": "Mr. Harry R. Trout III", "age": 55, "title": "Interim Principal Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen S. Capps CPA", "age": 40, "title": "Interim Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Viera", "title": "Executive Director of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nathaniel S. Gardiner J.D.", "age": 70, "title": "Consultant", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 672675, "exercisedValue": 49136, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tara Lynn Kieffer Ph.D.", "age": 46, "title": "Chief Product Strategy Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 496852, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brendan  Luu", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 622856, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.46, "open": 11.51, "dayLow": 10.86, "dayHigh": 11.51, "regularMarketPreviousClose": 11.46, "regularMarketOpen": 11.51, "regularMarketDayLow": 10.86, "regularMarketDayHigh": 11.51, "payoutRatio": 0.0, "beta": 0.894, "forwardPE": -2.286307, "volume": 295452, "regularMarketVolume": 295452, "averageVolume": 600631, "averageVolume10days": 2669280, "averageDailyVolume10Day": 2669280, "bid": 10.94, "ask": 11.12, "bidSize": 2, "askSize": 1, "marketCap": 317959232, "fiftyTwoWeekLow": 4.09, "fiftyTwoWeekHigh": 15.34, "allTimeHigh": 127.77, "allTimeLow": 4.09, "priceToSalesTrailing12Months": 4.906324, "fiftyDayAverage": 8.6936, "twoHundredDayAverage": 6.89275, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 238571712, "profitMargins": -1.41981, "floatShares": 15973798, "sharesOutstanding": 28852923, "sharesShort": 3350309, "sharesShortPriorMonth": 2833975, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.1567, "heldPercentInsiders": 0.05086, "heldPercentInstitutions": 0.66163003, "shortRatio": 2.85, "shortPercentOfFloat": 0.1665, "impliedSharesOutstanding": 28852923, "bookValue": 3.708, "priceToBook": 2.9719527, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -92012000, "trailingEps": -4.32, "forwardEps": -4.82, "enterpriseToRevenue": 3.681, "enterpriseToEbitda": -2.564, "52WeekChange": -0.025641024, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 11.02, "targetHighPrice": 28.0, "targetLowPrice": 9.0, "targetMeanPrice": 19.14286, "targetMedianPrice": 20.0, "recommendationMean": 1.57143, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 204111008, "totalCashPerShare": 9.548, "ebitda": -93036000, "totalDebt": 207098000, "quickRatio": 4.769, "currentRatio": 4.999, "totalRevenue": 64806000, "debtToEquity": 261.227, "revenuePerShare": 3.044, "returnOnAssets": -0.17292, "returnOnEquity": -0.80644, "grossProfits": 64806000, "freeCashflow": -30994500, "operatingCashflow": -23183000, "revenueGrowth": 0.019, "grossMargins": 1.0, "ebitdaMargins": -1.43561, "operatingMargins": -1.03162, "financialCurrency": "USD", "symbol": "ENTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyDayAverageChange": 2.3264008, "fiftyDayAverageChangePercent": 0.26759925, "twoHundredDayAverageChange": 4.1272507, "twoHundredDayAverageChangePercent": 0.59878147, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1363872600000, "postMarketChangePercent": -0.725961, "postMarketPrice": 10.94, "postMarketChange": -0.0800009, "regularMarketChange": -0.44, "regularMarketDayRange": "10.86 - 11.51", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 600631, "fiftyTwoWeekLowChange": 6.9300003, "fiftyTwoWeekLowChangePercent": 1.6943766, "fiftyTwoWeekRange": "4.09 - 15.34", "fiftyTwoWeekHighChange": -4.3199997, "fiftyTwoWeekHighChangePercent": -0.28161666, "fiftyTwoWeekChangePercent": -2.5641024, "earningsTimestampStart": 1764619200, "earningsTimestampEnd": 1764619200, "earningsCallTimestampStart": 1715027400, "earningsCallTimestampEnd": 1715027400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.32, "epsForward": -4.82, "epsCurrentYear": -3.74714, "priceEpsCurrentYear": -2.9409099, "corporateActions": [], "postMarketTime": 1760139480, "regularMarketTime": 1760126400, "shortName": "Enanta Pharmaceuticals, Inc.", "longName": "Enanta Pharmaceuticals, Inc.", "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_345286", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.83944, "regularMarketPrice": 11.02, "displayName": "Enanta Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]